She started working at the FDA in 1960 where she was tasked with reviewing new drug applications for U.S. approval. Among her frst assignments was a new drug ()evadon). Kelsey held up the application and asked Merrell for more information regarding its safety. By 1961 it became clear that thalidomide posed a serious safety risk.